Anika Therapeutics Inc (ANIK)

Cost of Revenue

$11.37M

Quarterly · Period ending: · USD

ANIK logo

ANIK Cost of Revenue

Latest reported$11.37M
ANIK Quarterly Cost of Revenue ($400.00K → $11.37M)
High-resolution chart · PNG

ANIK cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
2,109,049
1,744,686
3,105,703
2,549,516
2,077,003
940,597
700,000
1,600,000
1,600,000
1,400,000
1,400,000
1,200,000
1,400,000
1,300,000
1,600,000
800,000
1,100,000
900,000
800,000
800,000
1,200,000
1,100,000
700,000
1,100,000
800,000
300,000
700,000
900,000
900,000
1,000,000
800,000
800,000
400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.